Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Multiple Myeloma 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Burkitt Lymphoma 13Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Mantle-Cell 3Leukemia, Biphenotypic, Acute 3Smoldering Multiple Myeloma 2Recurrence 2Plasmacytoma 2Neoplasms 2Breast Neoplasms 2Blast Crisis 2Waldenstrom Macroglobulinemia 1Vomiting 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Pain 1Ovarian Neoplasms 1Neoplasm Metastasis 1Nausea 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Plasma Cell 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1

Interventions

Tamoxifen 6Radiotherapy 3Anastrozole 3Taxes 2Simvastatin 2Radiation 2Paclitaxel 2Neoadjuvant Therapy 2Letrozole 2Gene Expression Profiling 2Chemotherapy, Adjuvant 2Celecoxib 2telapristone acetate 1poly(I).poly(c12,U) 1oxybutynin 1liposomal doxorubicin 1exemestane 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Yoga 1Sugars 1Sentinel Lymph Node Biopsy 1Ranitidine 1Radiation Dose Hypofractionation 1Pharmacogenomic Testing 1Naltrexone 1Monitoring, Physiologic 1Mometasone Furoate 1Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Breast Carcinoma In Situ × auricularum × Clear all
NCT04862585 2025-08-20

Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel

Ohio State University Comprehensive Cancer Center

Phase 2/3 Completed
130 enrolled 8 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡